Giuseppe Fariselli

516 total citations
20 papers, 407 citations indexed

About

Giuseppe Fariselli is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Giuseppe Fariselli has authored 20 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Genetics. Recurrent topics in Giuseppe Fariselli's work include Breast Lesions and Carcinomas (10 papers), Estrogen and related hormone effects (7 papers) and Cancer Risks and Factors (5 papers). Giuseppe Fariselli is often cited by papers focused on Breast Lesions and Carcinomas (10 papers), Estrogen and related hormone effects (7 papers) and Cancer Risks and Factors (5 papers). Giuseppe Fariselli collaborates with scholars based in Italy, Malaysia and United States. Giuseppe Fariselli's co-authors include Giorgio Secreto, Camilla Recchione, Franco Berrino, Paolo Toniolo, S. Di Pietro, A Cavalleri, Sergio Di Pietro, Paola Pisani, Gaetano Bandieramonte and G Viganotti and has published in prestigious journals such as Annals of the New York Academy of Sciences, European Journal of Cancer and The Journal of Steroid Biochemistry and Molecular Biology.

In The Last Decade

Giuseppe Fariselli

19 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giuseppe Fariselli Italy 10 180 158 123 109 80 20 407
P. England United Kingdom 12 99 0.6× 82 0.5× 85 0.7× 65 0.6× 55 0.7× 23 325
J. L. Hayward United Kingdom 16 228 1.3× 151 1.0× 62 0.5× 77 0.7× 138 1.7× 21 473
J Jassem Poland 8 155 0.9× 140 0.9× 118 1.0× 34 0.3× 49 0.6× 23 318
Renzo Grattarola Italy 9 122 0.7× 161 1.0× 87 0.7× 25 0.2× 48 0.6× 32 318
Silvia Pecchio Italy 8 143 0.8× 67 0.4× 53 0.4× 72 0.7× 105 1.3× 13 306
Joseph V. Schlosser United States 12 113 0.6× 120 0.8× 54 0.4× 18 0.2× 40 0.5× 25 397
P. E. Burns Canada 9 146 0.8× 77 0.5× 16 0.1× 75 0.7× 102 1.3× 14 336
P Cohen United States 9 97 0.5× 131 0.8× 23 0.2× 43 0.4× 57 0.7× 20 347
Anna M. Ray United States 14 81 0.5× 167 1.1× 63 0.5× 74 0.7× 100 1.3× 25 482
Rosalind Wilson Australia 5 113 0.6× 148 0.9× 29 0.2× 278 2.6× 14 0.2× 12 371

Countries citing papers authored by Giuseppe Fariselli

Since Specialization
Citations

This map shows the geographic impact of Giuseppe Fariselli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Fariselli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Fariselli more than expected).

Fields of papers citing papers by Giuseppe Fariselli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Fariselli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Fariselli. The network helps show where Giuseppe Fariselli may publish in the future.

Co-authorship network of co-authors of Giuseppe Fariselli

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Fariselli. A scholar is included among the top collaborators of Giuseppe Fariselli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Fariselli. Giuseppe Fariselli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Secreto, Giorgio, et al.. (1996). Intratumour amount of sex steroids in elderly breast cancer patients. An approach to the biological characterization of mammary tumours in the elderly. The Journal of Steroid Biochemistry and Molecular Biology. 58(5-6). 557–561. 6 indexed citations
2.
Daidone, Maria Grazia, Gabriele Martelli, Silvana Pilotti, et al.. (1995). Contribution of ploidy and cell kinetics from fine‐needle aspirates for the diagnosis of breast lesions: Study of 606 consecutive cases. Cytometry. 22(3). 177–180. 2 indexed citations
3.
Zilembo, Nicoletta, Emilio Bajetta, Cristina Noberasco, et al.. (1993). 4-Hydroxyandrostenedione (4-OHA) as first line treatment in postmenopausal patients with advanced breast cancer(ABC). European Journal of Cancer. 29. S77–S77. 1 indexed citations
4.
Secreto, Giorgio, Camilla Recchione, Paola Ballerini, et al.. (1991). Accumulation of active androgens in breast cyst fluids. European Journal of Cancer and Clinical Oncology. 27(1). 44–47. 8 indexed citations
5.
Secreto, Giorgio, Paolo Toniolo, Franco Berrino, et al.. (1991). Serum and urinary androgens and risk of breast cancer in postmenopausal women.. PubMed. 51(10). 2572–6. 94 indexed citations
6.
Secreto, Giorgio, Camilla Recchione, Paola Ballerini, et al.. (1990). Cations and Active Androgens in Breast Cyst Fluida. Annals of the New York Academy of Sciences. 586(1). 88–92. 1 indexed citations
9.
Secreto, Giorgio, Paolo Toniolo, Paola Pisani, et al.. (1989). Androgens and breast cancer in premenopausal women.. PubMed. 49(2). 471–6. 68 indexed citations
10.
Secreto, Giorgio, Camilla Recchione, Milvia Zambetti, Giuseppe Fariselli, & Paola Ballerini. (1988). Hormonal changes induced by the pure antiandrogen flutamide in postmenopausal women with advanced breast cancer. European Journal of Cancer and Clinical Oncology. 24(5). 867–872. 12 indexed citations
11.
Fariselli, Giuseppe, et al.. (1988). Localized mastalgia as presenting symptom in breast cancer.. PubMed. 14(3). 213–5. 19 indexed citations
12.
Pietro, S. Di, Giuseppe Fariselli, Gaetano Bandieramonte, et al.. (1987). Diagnostic efficacy of the clinical-radiological-cytological triad in solid breast lumps: results of a second prospective study on 631 patients.. PubMed. 13(4). 335–40. 17 indexed citations
13.
Bono, Aldo, et al.. (1985). Inclusion cytology by fine needle biopsy in mammary tumors.. PubMed. 70(2). 119–20. 1 indexed citations
14.
Pietro, Sergio Di, et al.. (1985). Systematic Use of the Clinical-Mammographic-Cytologic Triplet for the Early Diagnosis of Mammary Carcinoma. Tumori Journal. 71(2). 179–185. 9 indexed citations
15.
Secreto, Giorgio, Paolo Toniolo, Franco Berrino, et al.. (1984). Increased androgenic activity and breast cancer risk in premenopausal women.. PubMed. 44(12 Pt 1). 5902–5. 48 indexed citations
16.
Secreto, Giorgio, et al.. (1984). High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast.. PubMed. 44(2). 841–4. 33 indexed citations
18.
Secreto, Giorgio, et al.. (1983). Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. European Journal of Cancer and Clinical Oncology. 19(1). 5–10. 35 indexed citations
19.
Bono, Aldo, et al.. (1982). Tamoxifen Therapy in Advanced Breast Cancer with Positive Estrogen Receptors in Postmenopausal Women. Tumori Journal. 68(2). 143–147. 1 indexed citations
20.
Salvadori, B, Giuseppe Fariselli, & Roberto Saccozzi. (1976). Analysis of 100 Cases of Paget's Disease of the Breast. Tumori Journal. 62(5). 529–535. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026